HaploX is a leading provider of genetic testing solutions, specializing in gene sequencing, liquid biopsies, bioinformatics, and big data analytics. Recognized for its technological innovation, HaploX is committed to advancing life sciences globally. Our laboratories are certified according to the highest standards for genetic testing globally, with accreditations from the CAP (College of American Pathologists), CLIA (Clinical Laboratory Improvement Amendments), and EMQN (European Molecular Genetics Quality Network). We excel in offering a broad spectrum of genetic testing applications, addressing various population groups, tumor types, and disease stages. Our services deliver valuable genetic testing results that support comprehensive health management, including cancer diagnostics, health screening, risk assessment, and pathogenic microbe testing.